Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Clinical trial NCT03093155 · COMPLETED

Trial details

NCT number: NCT03093155
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2017-04-03
Primary completion: 2022-12-29
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.